Figure S1 from Camrelizumab plus Famitinib in Patients with Advanced or Metastatic Renal Cell Carcinoma: Data from an Open-label, Multicenter Phase II Basket Study

Authors :: Ding-Wei Ye
Quanren Wang
Xiao Zhang
Jinling Cai
Chaohong He
Xuepei Zhang
Zhongquan Sun
Shujie Xia
Nianzeng Xing
Qing Zou
Hong Luo
Hongqian Guo
Hai-Liang Zhang
Yuan-Yuan Qu
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Basket trial design

Full Text Access

Tools